Tranexamic acid has one of the stranger origin stories in modern skincare. It is a prescription medication developed in the 1960s by a Japanese husband-and-wife research team, Utako and Shosuke Okamoto, to stop heavy bleeding. For half a century it was a standard part of post-surgical care and menstrual medicine. Then Japanese and Korean dermatologists noticed something unusual: patients on oral tranexamic acid for menorrhagia kept reporting that their melasma had faded.
That observation launched two decades of research and, eventually, a shelf of Korean brightening serums with "T.A." in the product name. In Canada, tranexamic acid has only recently moved from dermatology clinics into mainstream over-the-counter products. Here is what the ingredient actually does, why it is worth your attention, and how to use it without wasting money.
The mechanism, without oversimplifying
Most brightening ingredients target melanin production. Vitamin C inhibits tyrosinase. Kojic acid does similar. Arbutin is a prodrug for hydroquinone. All of these sit at the melanin-synthesis step.
Tranexamic acid works one layer upstream. It inhibits the plasminogen-plasmin system in the skin. Plasmin is an enzyme that, among other jobs, amplifies inflammation signals that tell melanocytes to produce more melanin. By blocking plasmin activation, tranexamic acid reduces the amplification loop before the melanocyte even decides to make melanin.
This is why tranexamic acid outperforms on melasma specifically. Melasma is not a simple overproduction of melanin - it is a chronic low-grade inflammation that keeps melanin production elevated even when there is no clear trigger. Plasmin is a central player in that chronicity. Interrupting it addresses the cause, not just the output.
Tranexamic Acid: a synthetic amino acid derivative that inhibits plasmin-driven inflammation and the downstream melanin pathway, particularly effective for melasma. See full entry.
Why Western brands ignored it for so long
Two reasons. First, the Western cosmetic industry had a solved problem for pigmentation - hydroquinone - that was legal at 2 percent over-the-counter in the United States until 2020. Hydroquinone worked fast. It was familiar. There was little commercial incentive to invest in a slower, gentler alternative.
Second, tranexamic acid has a narrower regulatory profile. As a prescription medication in Western markets, using it in cosmetics required careful formulation at sub-pharmaceutical concentrations and clear labeling. Korean and Japanese regulatory frameworks handled this distinction more gracefully, which is why the ingredient went mainstream in Asia a decade before it did here.
The 2020 FDA move to restrict hydroquinone availability in the US pushed Western formulators to look harder at Asian-market alternatives. Tranexamic acid was the obvious pick.
The clinical evidence
The most useful study for our purposes came out of Seoul National University in 2017. Fifty patients with bilateral melasma used a 5 percent tranexamic acid topical on one side of the face and a niacinamide vehicle on the other for 12 weeks. The tranexamic acid side showed significantly greater improvement in MASI (Melasma Area and Severity Index) scores, and the results held at the 8-week post-treatment follow-up.
A larger 2023 systematic review pooling 19 trials found consistent effect sizes for tranexamic acid at 2 to 5 percent topical concentrations. Above 5 percent, effect size did not improve. Below 2 percent, results became statistically noisy.
That 2 to 5 percent window is the usable range. Any Korean serum marketed as "tranexamic acid serum" with a labeled concentration in this range is formulating within the evidence.
Tranexamic acid versus the alternatives
Versus vitamin C
Vitamin C is an antioxidant-plus-tyrosinase-inhibitor. It prevents new melanin and also protects against the oxidative damage that triggers pigmentation. Tranexamic acid does not do the antioxidant job. They are complementary, not redundant.
For general brightening and anti-aging, vitamin C wins. For stubborn melasma, tranexamic acid wins. For both, use vitamin C in the morning and tranexamic acid in the evening. See our vitamin C showdown for current picks.
Versus niacinamide
Niacinamide interrupts the transfer of melanin to keratinocytes. Tranexamic acid interrupts the upstream signal. These layer beautifully and most Korean brightening serums combine both.
Niacinamide: a form of vitamin B3 that blocks melanin transport and calms redness. Pairs well with tranexamic acid. See full entry.
Versus arbutin and kojic acid
Arbutin and kojic acid are tyrosinase inhibitors in the vitamin C family. They are less potent than L-ascorbic acid but also more stable and gentler. Tranexamic acid addresses a different step. Stacking is safe.
How to use tranexamic acid
Evening routine, after cleansing and toner, before moisturizer. Apply a thin layer to affected areas. If you have bilateral melasma, apply to the full face rather than just spot-treating - the underlying inflammation pathway affects surrounding skin even where pigmentation is not yet visible.
Use daily for 12 weeks before evaluating results. This is the slowest-acting of the brightening ingredients. Patience is the price of a gentle mechanism.
Sunscreen in the morning is not optional. Without UV protection, the routine is fighting a tide.
The Korean products worth importing
We will not rank specific products here because the formulation landscape changes every six months. But a few markers of quality are stable.
Look for tranexamic acid in the top seven ingredients on the INCI list. If it is below phenoxyethanol, it is there for marketing rather than effect.
Prefer serums that combine tranexamic acid with niacinamide. The two ingredients work in complementary lanes and a single-product stack is more user-friendly than juggling two serums.
Packaging should be airless or amber. Tranexamic acid itself is stable, but the niacinamide and vitamin C derivatives that often accompany it are less so.
The Canadian angle
Two practical notes for Canadian buyers. Tranexamic acid in topical cosmetic concentrations is legal in Canada with no special documentation, but some Korean products that include it alongside skin-lightening claims (particularly those with hydroquinone-adjacent language) may be flagged at CBSA. Authorized Canadian retailers clear these through Health Canada's Cosmetics Notification pathway, which avoids customs delays.
Oral tranexamic acid, which is sometimes prescribed in Korea for stubborn melasma at 250 to 500 mg twice daily, is available in Canada only by prescription. It is worth a conversation with a Canadian dermatologist if your topical routine plateaus after six months. OHIP, RAMQ, and provincial coverage usually covers the consultation.
Bottom line
Tranexamic acid is the most important brightening ingredient that most Canadian consumers have still never heard of. It works through a mechanism that other brighteners do not touch, it layers safely with almost everything, and the Korean formulations have a decade-long head start on Western versions. For anyone with melasma or post-inflammatory pigmentation that has plateaued on vitamin C alone, a 2 to 5 percent tranexamic acid serum is the move.